DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Hyerin | ko |
dc.contributor.author | Chu, Jung Woong | ko |
dc.contributor.author | Park, Su Chan | ko |
dc.contributor.author | Im, Hyuntae | ko |
dc.contributor.author | Park, Il-Geun | ko |
dc.contributor.author | Kim, Hyunkyung | ko |
dc.contributor.author | Lee, Ji Min | ko |
dc.date.accessioned | 2022-02-21T06:41:27Z | - |
dc.date.available | 2022-02-21T06:41:27Z | - |
dc.date.created | 2022-02-21 | - |
dc.date.created | 2022-02-21 | - |
dc.date.created | 2022-02-21 | - |
dc.date.created | 2022-02-21 | - |
dc.date.issued | 2020-03 | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.21, no.5 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | http://hdl.handle.net/10203/292313 | - |
dc.description.abstract | The retinoid acid-related orphan receptor alpha (ROR alpha), a member of the orphan nuclear receptor superfamily, functions as an unknown ligand-dependent transcription factor. ROR alpha was shown to regulate a broad array of physiological processes such as Purkinje cell development in the cerebellum, circadian rhythm, lipid and bone metabolism, inhibition of inflammation, and anti-apoptosis. The human ROR alpha gene encodes at least four distinct isoforms (ROR alpha 1, -2, -3, -4), which differ only in their N-terminal domain (NTD). Two isoforms, ROR alpha 2 and 3, are not expressed in mice, whereas ROR alpha 1 and 4 are expressed both in mice and humans. In the present study, we identified the specific NTD of ROR alpha 2 that enhances prostate tumor progression and proliferation via lysine methylation-mediated recruitment of coactivator complex pontin/Tip60. Upregulation of the ROR alpha 2 isoform in prostate cancers putatively promotes tumor formation and progression. Furthermore, binding between coactivator complex and ROR alpha 2 is increased by lysine methylation of ROR alpha 2 because methylation permits subsequent interaction with binding partners. This methylation-dependent activation is performed by SET domain containing 7 (SETD7) methyltransferase, inducing the oncogenic potential of ROR alpha 2. Thus, post-translational lysine methylation of ROR alpha 2 modulates oncogenic function of ROR alpha 2 in prostate cancer. Exploration of the post-translational modifications of ROR alpha 2 provides new avenues for the development of tumor-suppressive therapeutic agents through modulating the human isoform-specific tumorigenic role of ROR alpha 2. | - |
dc.language | English | - |
dc.publisher | MDPI | - |
dc.title | Isoform-Specific Lysine Methylation of ROR alpha 2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression | - |
dc.type | Article | - |
dc.identifier.wosid | 000524908500073 | - |
dc.identifier.scopusid | 2-s2.0-85080854442 | - |
dc.type.rims | ART | - |
dc.citation.volume | 21 | - |
dc.citation.issue | 5 | - |
dc.citation.publicationname | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.identifier.doi | 10.3390/ijms21051622 | - |
dc.contributor.localauthor | Lee, Ji Min | - |
dc.contributor.nonIdAuthor | Song, Hyerin | - |
dc.contributor.nonIdAuthor | Chu, Jung Woong | - |
dc.contributor.nonIdAuthor | Kim, Hyunkyung | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | ROR alpha 2 | - |
dc.subject.keywordAuthor | oncogene | - |
dc.subject.keywordAuthor | prostate cancer | - |
dc.subject.keywordAuthor | N-terminal domain | - |
dc.subject.keywordAuthor | lysine methylation | - |
dc.subject.keywordPlus | ORPHAN NUCLEAR RECEPTOR | - |
dc.subject.keywordPlus | CHROMATIN-REMODELING COMPLEX | - |
dc.subject.keywordPlus | ROR-ALPHA | - |
dc.subject.keywordPlus | ANDROGEN RECEPTOR | - |
dc.subject.keywordPlus | SUPPRESSOR | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | ROLES | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | SUMOYLATION | - |
dc.subject.keywordPlus | REGULATOR | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.